Viewing SEC Facts Units
Company Name:
NeuBase Therapeutics, Inc.
CIK:
1173281
Start Filing Date:
2020-10-01
End Filing Date:
2021-09-30
ACCN:
0001410578-21-000599
Value:
$ 18,216,000
Value Error:
$ None
Created By:
Date Filed:
2021-12-23
FY:
2021
Fiscal Period:
FY
Frame:
CY2021
Type:
us-gaap
Form:
10-K
Units:
USD